Investor Invus, L.P.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Invus, L.P. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2024-12-09 13D/A LXRX / Lexicon Pharmaceuticals, Inc. 136,180,481 136,180,481
2024-07-29 13D/A LXRX / Lexicon Pharmaceuticals, Inc. 175,099,384 136,180,481
2024-05-14 13D/A LXRX / Lexicon Pharmaceuticals, Inc. 117,553,284 175,099,384
2024-03-13 13D/A LXRX / Lexicon Pharmaceuticals, Inc. 117,553,284 117,553,284
2023-06-06 13D/A LXRX / Lexicon Pharmaceuticals, Inc. 89,778,234 117,553,284
2022-08-09 13D/A LXRX / Lexicon Pharmaceuticals, Inc. 87,352,164 89,778,234
2022-08-01 13D/A LXRX / Lexicon Pharmaceuticals, Inc. 71,178,364 87,352,164
2021-01-21 13D/A LXRX / Lexicon Pharmaceuticals, Inc. 71,178,364 71,178,364
2021-01-05 13D/A LXRX / Lexicon Pharmaceuticals, Inc. 71,178,364 71,178,364
2020-12-16 13D/A LXRX / Lexicon Pharmaceuticals, Inc. 60,240,864 71,178,364
2018-06-29 13D/A LXRX / Lexicon Pharmaceuticals, Inc. 59,002,706 60,240,864
2018-06-04 13D/A LXRX / Lexicon Pharmaceuticals, Inc. 59,002,706
2017-02-13 13G/A BUFF / Innovator ETFs Trust - Innovator Laddered Allocation Power Buffer ETF 99,972,999 87,460,875
2016-07-07 13G/A BUFF / Innovator ETFs Trust - Innovator Laddered Allocation Power Buffer ETF 114,987,547 99,972,999
2016-02-16 13G BUFF / Innovator ETFs Trust - Innovator Laddered Allocation Power Buffer ETF 114,987,547
2014-11-26 13D/A LXRX / Lexicon Pharmaceuticals, Inc. 402,625,866
2012-10-26 13D/A LXRX / Lexicon Pharmaceuticals, Inc. 253,372,135
2012-04-10 13D/A LXRX / Lexicon Pharmaceuticals, Inc. 250,372,135
2012-02-24 13D/A LXRX / Lexicon Pharmaceuticals, Inc.